News

#Coronavirus | Valneva and Dynavax Announce Collaboration to Advance Vaccine Development for COVID-19

Valneva is leveraging its technical and platform capabilities to develop an inactivated, whole virus vaccine candidate against the current coronavirus... View Article

#Coronavirus | Eurofins Medical Device Testing commitment to support the safety and efficacy of devices used in the COVID-19 Crisis Response

NEWS PROVIDED BY Eurofins Medical Device Testing COVID-19 pandemic emergency is putting health care systems under severe strain, reflecting an... View Article

New member | CENTICH – VyV Group

The CENTICH is a private, non-profit organization, member of the French mutuality and the VyV group. It was created on... View Article

New member | Croda – Smart Science to Improve Lives

Established in 1925, Croda is the name behind high performance ingredients and technologies in some of the world’s biggest and... View Article

New member | Biowest – The serum specialist

Based in Nuaillé (Cholet), Biowest was founded in 1987. The company launched its activity by processing and distributing animal sera... View Article

Phase 3 Clinical Trial of Tedopi®: OSE Immunotherapeutics Announces Positive Top-Line Results for Step-1 of its trial ‘Atalante 1’ in Non-Small Cell Lung Cancer

• Step-1 primary endpoint met: 12-month survival rate in Tedopi® treated patients; • Complete analysis of Step-1 results and further... View Article

OSE Immunotherapeutics and Servier Amend the Global Licensing Option Agreement for IL-7R Antagonist OSE-127 in Autoimmune Diseases

Under this amendment, OSE Immunotherapeutics will receive a €5 million milestone payment at the start of the Sjögren’s Phase 2... View Article